Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background & Aims Substitution of lysine for glutamic acid at residu 167 in Transmembrane 6 superfamily member 2 (TM6SF2) is associated with fatty liver disease and reduced plasma lipid levels. Tm6sf2 -/- mice replicate the human phenotype but were not suitable for detailed mechanistic studies. As an alternative model, we generated Tm6sf2 -/- rats to determine the subcellular location and function of TM6SF2. Methods Two lines of Tm6sf2 -/- rats were established using gene editing. Lipids from tissues and from newly secreted very low density lipoproteins (VLDLs) were quantified using enzymatic assays and mass spectrometry. Neutral lipids were visualized in tissue sections using Oil Red O staining. The rate of dietary triglyceride (TG) absorption and hepatic VLDL-TG secretion were compared in Tm6sf2 -/- mice and in their wild-type littermates. The intracellular location of TM6SF2 was determined by cell fractionation. Finally, TM6SF2 was immunoprecipitated from liver and enterocytes to identify interacting proteins. Results Tm6sf2 -/- rats had a 6-fold higher mean hepatic TG content (56.1 ± 28.9 9 vs 9.8 ± 3.9 mg/g; P < .0001) and lower plasma cholesterol levels (99.0 ± 10.5 vs 110.6 ± 14.0 mg/dL; P = .0294) than their wild-type littermates. Rates of appearance of dietary and hepatic TG into blood were reduced significantly in Tm6sf2 -/- rats ( P < .001 and P < .01, respectively). Lipid content of newly secreted VLDLs isolated from perfused livers was reduced by 53% (TG) and 62% (cholesterol) ( P = .005 and P = .01, respectively) in Tm6sf2 -/- mice. TM6SF2 was present predominantly in the smooth endoplasmic reticulum and endoplasmic reticulum–Golgi intermediate compartments, but not in Golgi. Both apolipoprotein B-48 and acyl-CoA synthetase long chain family member 5 physically interacted with TM6SF2. Conclusions TM6SF2 acts in the smooth endoplasmic reticulum to promote bulk lipidation of apolipoprotein B–containing lipoproteins, thus preventing fatty liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Self-citationHuman Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · cited 1×
“Similar genetic factors confer susceptibility to both forms of FLD, consistent with the notion that these 2 disorders share key mechanistic factors.(2,3) The 2 strongest genetic risk factors for FLD are missense variants in patatin phospholipase-like domain containing protein 3 (PNPLA3)(4) and in transmembrane 6 super…”
BackgroundSelf-citationKozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234 · cited 6×
“Heterozygous mice (Tm6sf2þ/-) had levels of plasma TG and cholesterol that were intermediate between those of WT and homozygous KO mice,(9) which is consistent with the human data.(5) However, plasma lipid levels of heterozygous rats (Tm6sf2þ/-) did not differ from WT littermates.”
BackgroundResultSelf-citationSpeliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Buch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3417 · Cited by 565 · cited 1×
“Similar genetic factors confer susceptibility to both forms of FLD, consistent with the notion that these 2 disorders share key mechanistic factors.(2,3) The 2 strongest genetic risk factors for FLD are missense variants in patatin phospholipase-like domain containing protein 3 (PNPLA3)(4) and in transmembrane 6 super…”
BackgroundHammond, C., & Helenius, A. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.41 · Cited by 443 · cited 3×
“The postnuclear supernatant (600 mL) was subjected to Nycodenz continuous gradient centrifugation as described previously.(22) The gradients were centrifuged at 234,200g (37,000 rpm) in a TH-641 rotor for 2 hours and then at 175,200g (32,000 rpm) for 16 hours (no brake).”
MethodInfluentialMahdessian, H., Taxiarchis, A., Popov, S., Silveira, A., Franco-Cereceda, A., Hamsten, A., Eriksson, P., & van't Hooft, F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323785111 · Cited by 369 · cited 2×
“TM6SF2 is a polytopic membrane protein that is required for bulk lipidation of very low density lipoprotein (VLDL).(5,7,8) The E167K substitution destabilizes TM6SF2, conferring a loss of function.”
BackgroundCappel, D. A., Deja, S., Duarte, J. A. G., Kucejova, B., Iñigo, M., Fletcher, J. A., Fu, X., Berglund, E. D., Liu, T., Elmquist, J. K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.014 · Cited by 242 · cited 1×
“Livers were harvested and perfused without recirculation for 60 min as described previously.(39) Briefly, mice were anesthetized, intraperitoneal heparin was administered, and the portal vein was cannulated and perfused using a modified Krebs-Henseleit buffer containing 1.”
MethodSelf-citationSmagris, E., Gilyard, S., BasuRay, S., Cohen, J. C., & Hobbs, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719955 · Cited by 226
Self-citationMashek, D. G., McKenzie, M. A., Van Horn, C. G., & Coleman, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507646200 · Cited by 129
Cited by
NAFLD: Mechanisms, Treatments, and Biomarkers
Nassir, F. (2022) · Biomolecules · doi:10.3390/biom12060824 · Cited by 405
Updated mechanisms of MASLD pathogenesis
Li, Y., Yang, P., Ye, J., Xu, Q., Wu, J., & Wang, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02108-x · Cited by 300
Chen, J., Fang, Z., Luo, Q., Wang, X., Warda, M., Das, A., Oldoni, F., & Luo, F. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-023-01993-y · Cited by 47
“The lipidation of very low-density lipoprotein (VLDL) is a two-step process [14, 16, 17].”
BackgroundInfluentialSelf-citationFan, W., Bradford, T. M., & Török, N. J. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15184 · Cited by 25
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Liu, J., Ginsberg, H. N., & Reyes-Soffer, G. (2024) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000930 · Cited by 19
Metadata
- Authors
- Luo, F., Smagris, E., Martin, S. A., Vale, G., McDonald, J. G., Fletcher, J. A., Burgess, S. C., Hobbs, H. H., & Cohen, J. C.
- Venue
- Cellular and Molecular Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2022
- Volume
- 13
- Issue
- 3
- Pages
- 879-899
- ISSN
- 2352-345X (ISSN-L)
- OpenAlex
- W4200415237
- Cited by
- 97
- References
- 13
- FWCI
- 14.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats. https://app.cochat.ai/papers/10.1016/j.jcmgh.2021.12.008
- The paper
- Luo, F., Smagris, E., Martin, S. A., Vale, G., McDonald, J. G., Fletcher, J. A., Burgess, S. C., Hobbs, H. H., & Cohen, J. C. (2022). Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats. Cellular and Molecular Gastroenterology and Hepatology. https://doi.org/10.1016/j.jcmgh.2021.12.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.